These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2813411)
1. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine. Price PM; Banerjee R; Acs G Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8541-4. PubMed ID: 2813411 [TBL] [Abstract][Full Text] [Related]
2. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine. Price PM; Banerjee R; Jeffrey AM; Acs G Hepatology; 1992 Jul; 16(1):8-12. PubMed ID: 1319957 [TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. Aoki-Sei S; O'Brien MC; Ford H; Fujii H; Gilbert DA; Cooney DA; Johns DG; Broder S; Mitsuya H J Infect Dis; 1991 Nov; 164(5):843-51. PubMed ID: 1940465 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells. Kawanishi Y; Hayashi N; Katayama K; Ueda K; Takehara T; Miyoshi E; Mita E; Kasahara A; Fusamoto H; Kamada T J Med Virol; 1995 Nov; 47(3):272-7. PubMed ID: 8551280 [TBL] [Abstract][Full Text] [Related]
5. [Inhibition of replication of human hepatitis B virus]. Tsibinogin VV; KraevskiÄ AA; Bibilashvili RSh; Gren EIa; Kiselev LL Mol Biol (Mosk); 1989; 23(4):983-7. PubMed ID: 2586511 [TBL] [Abstract][Full Text] [Related]
6. A cell culture assay for compounds which inhibit hepatitis B virus replication. Korba BE; Milman G Antiviral Res; 1991; 15(3):217-28. PubMed ID: 1716089 [No Abstract] [Full Text] [Related]
7. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Shaw T; Mok SS; Locarnini SA Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366 [TBL] [Abstract][Full Text] [Related]
8. An in vitro system for screening anti-hepatitis B virus drugs. Ueda K; Tsurimoto T; Nagahata T; Chisaka O; Matsubara K Virology; 1989 Mar; 169(1):213-6. PubMed ID: 2466368 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro anti-hepatitis B virus activity of ethyl 6-bromo-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylates. Chen D; Liu Y; Zhang S; Guo D; Liu C; Li S; Gong P Arch Pharm (Weinheim); 2011 Mar; 344(3):158-64. PubMed ID: 21384414 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugs. Galle PR; Theilmann L Arzneimittelforschung; 1990 Dec; 40(12):1380-2. PubMed ID: 2095136 [TBL] [Abstract][Full Text] [Related]
11. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors. Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116 [TBL] [Abstract][Full Text] [Related]
12. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus. Hu K; Huang Y; Mu J; Cheng Z; Zhu X Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818 [TBL] [Abstract][Full Text] [Related]
13. Quantitative polymerase chain reaction for hepatitis B virus DNA. Wu J; Sullivan DE; Gerber MA J Virol Methods; 1994 Oct; 49(3):331-41. PubMed ID: 7868650 [TBL] [Abstract][Full Text] [Related]
14. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Delaney WE; Locarnini S; Shaw T Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine. Ojwang JO; Bhattacharya BK; Marshall HB; Korba BE; Revankar GR; Rando RF Antimicrob Agents Chemother; 1995 Nov; 39(11):2570-3. PubMed ID: 8585748 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles. Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058 [TBL] [Abstract][Full Text] [Related]
17. Phosphonylmethoxyalkyl derivatives of purine as inhibitors of human hepatitis B virus DNA synthesis. Yokota T; Mochizuki S; Konno K; Mori S; Shigeta S; De Clercq E Nucleic Acids Symp Ser; 1990; (22):17-8. PubMed ID: 2101900 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of metachromin A on hepatitis B virus production via impairment of the viral promoter activity. Yamashita A; Tamaki M; Kasai H; Tanaka T; Otoguro T; Ryo A; Maekawa S; Enomoto N; de Voogd NJ; Tanaka J; Moriishi K Antiviral Res; 2017 Sep; 145():136-145. PubMed ID: 28827084 [TBL] [Abstract][Full Text] [Related]
20. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication. Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]